F. Kradolfer
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Antibiotics Pharmacokinetics and Efficacy
- Microbiology top 10%
Papers in
- Pharmacology 12
- Microbial Natural Products and Biosynthesis 8
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Synthetic Organic Chemistry Methods 6
- Co-authors
- L. Neipp (11 shared papers)L. Ettlinger (8 shared papers)E. Gäumann (7 shared papers)V. Prelog (7 shared papers)O. Zák (2 shared papers)Hans Zähner (6 shared papers)R. Corbaz (5 shared papers)W. Keller‐Schierlein (6 shared papers)
- Journals
- Helvetica Chimica Acta (7 papers)Cellular and Molecular Life Sciences (4 papers)Chemotherapy (2 papers)Archives of Virology (1 paper)Experimental Parasitology (1 paper)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
F. Kradolfer
30 papers receiving 481 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 218
- Microbiology 9
- Molecular Medicine 56
- Organic Chemistry 221
- Biotechnology 48
Countries citing papers authored by F. Kradolfer
This map shows the geographic impact of F. Kradolfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Kradolfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Kradolfer more than expected).
Fields of papers citing papers by F. Kradolfer
This network shows the impact of papers produced by F. Kradolfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Kradolfer. The network helps show where F. Kradolfer may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Kradolfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1957 | 77 | |
| 2 | 1955 | 74 | |
| 3 | 1979 | 59 | |
| 4 | 1957 | 56 | |
| 5 | 1959 | 52 | |
| 6 | 1964 | 44 | |
| 7 | 1955 | 38 | |
| 8 | 1956 | 30 | |
| 9 | 1958 | 24 | |
| 10 | 1976 | 21 | |
| 11 | 1956 | 14 | |
| 12 | Ferrimycin A, a new iron-containing antibiotic. | 1962 | 13 |
| 13 | Mode of action of Ciba 32644-Ba in experimental schistosomiasis. | 1966 | 9 |
| 14 | 1955 | 8 | |
| 15 | 1957 | 8 | |
| 16 | 1969 | 8 | |
| 17 | 1955 | 5 | |
| 18 | Chemotherapeutic activity of new derivatives of rifamycin. | 1966 | 5 |
| 19 | 1957 | 4 | |
| 20 | 1960 | 4 |
About F. Kradolfer
F. Kradolfer is a scholar working on Pharmacology, Organic Chemistry, Infectious Diseases, Molecular Biology and Epidemiology, having authored 41 papers that have together received 581 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (8 papers), Tuberculosis Research and Epidemiology (6 papers), Synthetic Organic Chemistry Methods (6 papers), Mycobacterium research and diagnosis (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Chemical Synthesis and Analysis (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Parasites and Host Interactions (3 papers). The work is most often cited by research in Pharmacology (218 citations), Microbiology (9 citations), Molecular Medicine (56 citations), Organic Chemistry (221 citations) and Biotechnology (48 citations). F. Kradolfer has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include L. Neipp, L. Ettlinger, E. Gäumann, V. Prelog, O. Zák, Hans Zähner, R. Corbaz, W. Keller‐Schierlein, P Reusser and R. Meier. Their work appears in journals such as Helvetica Chimica Acta, Cellular and Molecular Life Sciences, Chemotherapy, Archives of Virology and Experimental Parasitology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.